Amundi Asset Management US’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$119M Buy
1,322,136
+362,720
+38% +$34M 0.09% 237
2020
Q4
$88.7M Sell
959,416
-2,832
-0.3% -$253K 0.08% 275
2020
Q3
$99.2M Buy
962,248
+772
+0.1% +$80.7K 0.1% 209
2020
Q2
$97.4M Sell
961,476
-57,584
-6% -$5.15M 0.12% 185
2020
Q1
$68.6M Sell
1,019,060
-10,344
-1% -$644K 0.12% 163
2019
Q4
$56.3M Sell
1,029,404
-146,812
-12% -$6.96M 0.07% 288
2019
Q3
$43.9M Buy
1,176,216
+132,908
+13% +$5.16M 0.07% 307
2019
Q2
$39.1M Buy
1,043,308
+234,648
+29% +$7.38M 0.03% 385
2019
Q1
$24.1M Buy
808,660
+83,652
+12% +$2.94M 0.03% 470
2018
Q4
$21.7K Buy
725,008
+180,596
+33% +$5.73M 0.02% 456
2018
Q3
$19.5M Buy
+544,412
New +$16.9M 0.03% 543

Other funds holding DXCM

Amundi Asset Management US's DXCM Position: Q1 2021 in Review

Amundi Asset Management US increased its DexCom (DXCM) stake by 38% in Q1 2021, buying an estimated $34M and bringing the position to 1,322,136 shares worth $119M. The position accounts for 0.09% of the portfolio, ranked #237.

Amundi Asset Management US first reported a position in DXCM in Q3 2018 and has held it in 11 quarters since. 730 funds tracked by Wall St. Rank hold DXCM as of Q1 2021.

  • Amundi Asset Management US held 1,322,136 shares of DexCom worth $119M as of Q1 2021.
  • Amundi Asset Management US bought 362,720 DexCom shares in Q1 2021, an estimated $34M.
  • DexCom made up 0.09% of Amundi Asset Management US's portfolio in Q1 2021, its #237 holding.
  • Amundi Asset Management US first reported a position in DexCom in Q3 2018 and has held it in 11 quarters since.
  • 730 funds tracked by Wall St. Rank held DexCom as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.